My blogging buddy and one of our members Sarah from bi[polar] curious posted this excellent piece which I think will interest a lot of our members. Many thanks go to Sarah for allowing me to reblog her post here.
I stumbled upon some interesting news this morning, the FDA has just accepted a resubmission of an action letter from Alexza Pharmaceuticals in regard to a drug called Adasuve (Staccato Loxapine). From what I can tell, this is a drug that may already be used, but the difference will come from the way the drug is taken.
The drug will be inhaled through an inhaler to provide almost immediate relief, which sounds like a pretty interesting idea (to me, anyway). You can check out a video with a nifty animation of how the Staccato inhaler works here.
Apart from this new inhaler system being something that caught my eye, the other prospect I consider exciting is that this is intended for use for patients with Schizophrenia & Bipolar Type I who experience agitation.
Personally, agitation is something I experience fairly often, and it is one of the most uncomfortable things ever. And…
View original post 97 more words